Profile | GDS5420 / 224920_x_at |
Title | Psoriasis response to brodalumab: dose response and time course |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM1296094 | A_lesional_pre-dose | 510.03 | 68 |
GSM1296119 | B_lesional_pre-dose | 1564.53 | 86 |
GSM1296076 | C_lesional_pre-dose | 1161.17 | 81 |
GSM1296092 | D_lesional_pre-dose | 879.64 | 77 |
GSM1296103 | E_lesional_pre-dose | 443.99 | 65 |
GSM1296078 | F_lesional_pre-dose | 1281.68 | 82 |
GSM1296107 | G_lesional_pre-dose | 1338.22 | 84 |
GSM1296109 | H_lesional_pre-dose | 833.19 | 76 |
GSM1296080 | I_lesional_pre-dose | 236.2 | 56 |
GSM1296090 | J_lesional_pre-dose | 1609.76 | 86 |
GSM1296074 | K_lesional_pre-dose | 1016.16 | 79 |
GSM1296111 | L_lesional_pre-dose | 1552.35 | 86 |
GSM1296099 | M_lesional_pre-dose | 949.95 | 78 |
GSM1296086 | O_lesional_pre-dose | 1354.16 | 83 |
GSM1296117 | P_lesional_pre-dose | 1027.68 | 80 |
GSM1296113 | Q_lesional_pre-dose | 1192.89 | 82 |
GSM1296096 | R_lesional_pre-dose | 1025.85 | 79 |
GSM1296105 | S_lesional_pre-dose | 1229.86 | 82 |
GSM1296098 | T_lesional_pre-dose | 287.65 | 58 |
GSM1296101 | U_lesional_pre-dose | 1476.6 | 85 |
GSM1296121 | V_lesional_pre-dose | 1504.22 | 85 |
GSM1296088 | W_lesional_pre-dose | 1733 | 87 |
GSM1296082 | X_lesional_pre-dose | 1150.34 | 81 |
GSM1296115 | Y_lesional_pre-dose | 1599.49 | 86 |
GSM1296084 | Z_lesional_pre-dose | 1736.31 | 87 |
GSM1296072 | B_lesional_day8 | 1464.94 | 85 |
GSM1296069 | L_lesional_day8 | 2059.91 | 90 |
GSM1296071 | P_lesional_day8 | 2106.83 | 91 |
GSM1296070 | Y_lesional_day8 | 1801.73 | 88 |
GSM1296073 | V_lesional_day8 | 1208.66 | 82 |
GSM1296034 | A_lesional_day15 | 635.84 | 71 |
GSM1296041 | G_lesional_day15 | 1197.62 | 82 |
GSM1296035 | R_lesional_day15 | 1129.98 | 81 |
GSM1296038 | U_lesional_day15 | 1859.4 | 88 |
GSM1296047 | B_lesional_day15 | 1754.89 | 88 |
GSM1296039 | E_lesional_day15 | 865.17 | 77 |
GSM1296042 | H_lesional_day15 | 1630.81 | 87 |
GSM1296043 | L_lesional_day15 | 2122.1 | 91 |
GSM1296037 | M_lesional_day15 | 1768.89 | 88 |
GSM1296046 | P_lesional_day15 | 1755.78 | 88 |
GSM1296044 | Q_lesional_day15 | 1903.55 | 89 |
GSM1296045 | Y_lesional_day15 | 2313.5 | 92 |
GSM1296025 | C_lesional_day15 | 1470.43 | 85 |
GSM1296033 | D_lesional_day15 | 1215.57 | 82 |
GSM1296027 | I_lesional_day15 | 1626.05 | 86 |
GSM1296032 | J_lesional_day15 | 1409.1 | 84 |
GSM1296024 | K_lesional_day15 | 1461.38 | 85 |
GSM1296031 | W_lesional_day15 | 3974.07 | 96 |
GSM1296028 | X_lesional_day15 | 1691.59 | 87 |
GSM1296029 | Z_lesional_day15 | 2441.94 | 92 |
GSM1296026 | F_lesional_day15 | 1152.75 | 81 |
GSM1296030 | O_lesional_day15 | 1081.05 | 80 |
GSM1296040 | S_lesional_day15 | 719.29 | 74 |
GSM1296036 | T_lesional_day15 | 420.4 | 64 |
GSM1296048 | V_lesional_day15 | 2277.71 | 91 |
GSM1296059 | A_lesional_day43 | 1266.9 | 83 |
GSM1296066 | G_lesional_day43 | 1585.31 | 86 |
GSM1296060 | R_lesional_day43 | 1125.43 | 81 |
GSM1296063 | U_lesional_day43 | 2459.16 | 91 |
GSM1296064 | E_lesional_day43 | 1521.68 | 85 |
GSM1296067 | H_lesional_day43 | 2176.13 | 91 |
GSM1296062 | M_lesional_day43 | 749.92 | 74 |
GSM1296068 | Q_lesional_day43 | 2121.63 | 91 |
GSM1296050 | C_lesional_day43 | 2314.87 | 91 |
GSM1296057 | D_lesional_day43 | 1934.45 | 89 |
GSM1296052 | I_lesional_day43 | 2014.84 | 89 |
GSM1296054 | J_lesional_day43 | 1264.52 | 83 |
GSM1296049 | K_lesional_day43 | 1251.86 | 82 |
GSM1296055 | W_lesional_day43 | 5004.73 | 97 |
GSM1296053 | X_lesional_day43 | 1637.52 | 87 |
GSM1296058 | Z_lesional_day43 | 2482.94 | 92 |
GSM1296051 | F_lesional_day43 | 2178.19 | 90 |
GSM1296056 | O_lesional_day43 | 1704.84 | 86 |
GSM1296065 | S_lesional_day43 | 1390.96 | 84 |
GSM1296061 | T_lesional_day43 | 432.63 | 64 |
GSM1296095 | A_non-lesional_pre-dose | 2350.47 | 91 |
GSM1296120 | B_non-lesional_pre-dose | 1739.16 | 88 |
GSM1296077 | C_non-lesional_pre-dose | 2307.04 | 91 |
GSM1296093 | D_non-lesional_pre-dose | 1433.6 | 85 |
GSM1296104 | E_non-lesional_pre-dose | 2562.42 | 91 |
GSM1296079 | F_non-lesional_pre-dose | 2464.79 | 91 |
GSM1296108 | G_non-lesional_pre-dose | 1998.69 | 89 |
GSM1296110 | H_non-lesional_pre-dose | 2018.1 | 90 |
GSM1296081 | I_non-lesional_pre-dose | 1685.79 | 86 |
GSM1296091 | J_non-lesional_pre-dose | 1487.21 | 85 |
GSM1296075 | K_non-lesional_pre-dose | 2908.77 | 93 |
GSM1296112 | L_non-lesional_pre-dose | 2536.95 | 93 |
GSM1296100 | M_non-lesional_pre-dose | 1549.24 | 86 |
GSM1296087 | O_non-lesional_pre-dose | 2042.52 | 89 |
GSM1296118 | P_non-lesional_pre-dose | 1786.7 | 89 |
GSM1296114 | Q_non-lesional_pre-dose | 2035.78 | 90 |
GSM1296097 | R_non-lesional_pre-dose | 2302.83 | 91 |
GSM1296106 | S_non-lesional_pre-dose | 1688.15 | 87 |
GSM1296102 | U_non-lesional_pre-dose | 1929.59 | 89 |
GSM1296122 | V_non-lesional_pre-dose | 2047.99 | 90 |
GSM1296089 | W_non-lesional_pre-dose | 4387.85 | 97 |
GSM1296083 | X_non-lesional_pre-dose | 2121.9 | 90 |
GSM1296116 | Y_non-lesional_pre-dose | 2284.66 | 92 |
GSM1296085 | Z_non-lesional_pre-dose | 1714.19 | 87 |